The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

head of the HIV Prevention Trials Network says there are four areas of research which are being investigated in HIV; ...

In an ongoing clinical trial, researchers are testing whether just one dose of a new gene therapy that might effectively cure human immunodeficiency virus (HIV) infections is safe in humans.

DRIVE-AHEAD included 728 patients not previously treated for HIV who were ... After 48 weeks of treatment, viral suppression rates were comparable between the two study groups, indicating that ...

Dr Philip Arandjelovic, co-author in the study, said the discovery is an exciting step towards developing treatment options for the tens of millions of people currently living with HIV globally.

Dolutegravir is an HIV integrase ... with few treatment discontinuations due to adverse effects. Headache, nausea and diarrhea were the most likely side effects reported in clinical trials.

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic ... into a phase 1/2 clinical trial in patients with chronic HIV infection with the proceeds ...

“Novel HIV treatment options that allow for less frequent ... the combination and Biktarvy cohorts at Week 48 of the phase 2 trial. No participants discontinued because of a decrease in CD4 ...

As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. Recent clinical trials and global ...

The study is based on data from the national HIV ... stigma and, not least, HIV cure. "Research on HIV cure is now a top priority," says Prof. Sönnerborg Researchers at Karolinska Institutet ...